Evidence map›Paper›PMID 30918265›Full record

ReviewNature communications2019

Systematic benchmarking of omics computational tools.

Serghei Mangul, Lana S Martin, Brian L Hill, Angela Ka-Mei Lam, Margaret G Distler, Alex Zelikovsky, Eleazar Eskin, Jonathan Flint

Abstract readReview
In one paragraph

Review in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Article
  5. Article
  6. The dark genome in cardiovascular medicine.European heart journal · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Analysis of metagenomic data.Nature reviews. Methods primers · 2025
    Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Serghei MangulDepartment of Computer Science, University of California Los Angeles, 580 Portola Plaza, Los Angeles, CA, 90095, USA. smangul@ucla.edu.
Lana S MartinInstitute for Quantitative and Computational Biosciences, University of California Los Angeles, 611 Charles E Young Drive East, Los Angeles, CA, 90095, USA.
Brian L HillDepartment of Computer Science, University of California Los Angeles, 580 Portola Plaza, Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0002-6881-5770
Angela Ka-Mei LamDepartment of Computer Science, University of California Los Angeles, 580 Portola Plaza, Los Angeles, CA, 90095, USA.
Margaret G DistlerDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
Alex ZelikovskyDepartment of Computer Science, Georgia State University, Atlanta, GA, 30303, USA.ORCID http://orcid.org/0000-0003-4424-4691
Eleazar EskinDepartment of Computer Science, University of California Los Angeles, 580 Portola Plaza, Los Angeles, CA, 90095, USA.
Jonathan FlintDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.

Funding

QUBBD: VIRAL EVOLUTION AND SPREAD OF INFECTIOUS DISEASE IN COMPLEX NETWORK: BIG DATA ANALYSIS AND MODELINGR01EB025022 · NIBIB · GEORGIA STATE UNIVERSITY · PI SKUMS, PAVEL, VANNBERG, FREDRIK · 2017 to 2019
$891k
NIBIB NIH HHS R01 EB025022
6 · The paper itself

Abstract

Computational omics methods packaged as software have become essential to modern biological research. The increasing dependence of scientists on these powerful software tools creates a need for systematic assessment of these methods, known as benchmarking. Adopting a standardized benchmarking practice could help researchers who use omics data to better leverage recent technological innovations. Our review summarizes benchmarking practices from 25 recent studies and discusses the challenges, advantages, and limitations of benchmarking across various domains of biology. We also propose principles that can make computational biology benchmarking studies more sustainable and reproducible, ultimately increasing the transparency of biomedical data and results.

Indexed as

BenchmarkingComputational BiologyGenomicsSoftwareHumansMetabolomics

Identifiers

PMID30918265
PMCPMC6437167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.